跳至主要内容
临床试验/IRCT20170315033086N10
IRCT20170315033086N10已完成2 期

Evaluation of the effect of inflawell-syrup on the immune response and the signaling pathway of NF-kB in peripheral blood mononuclear cell in patients with COVID-19: Double blind, placebo-controlled randomized clinical trial

Shahid Beheshti University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • COVID-19 patient admitted to the infectious ward of the hospital
  • Age = 18 years in both sexes
  • Confirmation of SARS-CoV2 infection based on PCR test and clinical manifestations including: 1. Respiratory distress (breathing = 25 times per minute) or 2. Percentage of oxygen saturation at rest =92%
  • Early diagnosis (less than or equal to 8 days from the onset of symptoms)
  • Signing the informed consent form

排除标准

  • Liver, kidney and heart failure
  • Inability of the patient to consume the oral form
  • Pregnancy and lactation or positive pregnancy test
  • Participate in two or more clinical trials simultaneously

研究者

相似试验

Investigation of the efficacy of inflawell syrup on... | 临床试验